Adjuvants has a prospect of becoming next-generation immune drugs, and this project aims to establish a database in which biomarkers can be explored contributing to research and development (efficacy) and to regulatory review (safety).
For the details, please refer to Overview of Adjuvant Database Project
Health Labour Sciences Research Grant
'Development of a database to evaluate adjuvant safety'